Bär & Karrer Advised Screening Eagle Technologies and its Majority Shareholder on the CHF 55 Million
Screening Eagle Technologies, a cloud-based technology platform connecting sensors, software, and data for intelligent inspection of assets and infrastructure, has raised CHF 55 million in its first institutional round of equity funding.
Bär & Karrer Advised the Banking Syndicate on the Acquisition Financing of ams for Osram
On 3 April 2020, ams AG completed a capital increase by way of a rights offering raising gross proceeds of approximately CHF 1.75 billion. The proceeds will be used to partially finance the acquisition of OSRAM Licht AG. The banking syndicate was led by HSBC and UBS acting as joint global coordinators.
Bär & Karrer Advised on Santhera’s up to CHF 24 Million Equity-Linked Financing
Santhera Pharmaceuticals Holding AG announced that it has entered into an equity-linked financing arrangement with IRIS (France) in the initial gross amount of up to CHF 12 million over 12 months, with the option to extend by another CHF 12 million over another 12 months. This innovative financing instruments provides Santhera with a liquidity line …
Continue reading “Bär & Karrer Advised on Santhera’s up to CHF 24 Million Equity-Linked Financing”
Bär & Karrer Advises Nouryon on the Divestment of its Redispersible Polymer Powders Business
Nouryon, a global chemical company, divested its redispersible polymer powders (RPP) business, offered under the Elotex brand, to Celanese Corporation.
Bär & Karrer Advised Maxburg Beteiligungen III GmbH & Co. KG on the Acquisition of saracus consult
Maxburg Beteiligungen III GmbH & Co. KG (“Maxburg”), advised by Maxburg Capital Partners has purchased saracus group, an IT consultancy firm based in Germany and Switzerland.
Bär & Karrer Advised Banque Cantonale de Genève on the Increase of the Capital of La Foncière
La Foncière, a real estate fund governed by articles 58 et seq. of the Swiss Collective Investment Schemes Act, completed from 16 to 25 March 2020 an increase by 10% of the number of its units (parts) listed on the SIX Swiss Exchange. The 1’237’107 additional units were fully subscribed to, in spite of most …
Bär & Karrer Advises Shareholders of Solvias in Connection with Investment by Water Street
Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced that it has signed a definitive agreement to invest in Solvias AG, one of the largest independent pharmaceutical laboratory platforms in Europe.
Bär & Karrer Advises Novartis on the Financing of the Acquisition of The Medicines Company
In connection with the acquisition of NASDAQ-listed biopharmaceutical company The Medicines Company for USD 9.7 billion, Novartis AG and Novartis Finance Corporation entered into a USD 7 billion short-term (bridge) credit agreement and completed a USD 5 billion four-tranche SEC-registered bond offering. Bär & Karrer acted as Swiss legal advisor to Novartis in this transaction.
Bär & Karrer Advised Open Systems on the purchase of Sqooba
EQT portfolio company Open Systems AG, a secure access service edge (SASE) pioneer, has acquired Sqooba (Schweiz) AG from its founders. Sqooba is a Swiss-based leader in big data analytics.
Bär & Karrer Advises la Mobilière on the Acquisition of a 25% Stake in Ringier
La Mobilière acquires a stake of 25% of the shares in Ringier AG. The share purchase is to be completed in the first half of 2020.